D-Cateslytin: a new antifungal agent for the treatment of oral Candida albicans associated infections

The excessive use of antifungal agents, compounded by the shortage of new drugs being introduced into the market, is causing the accumulation of multi-resistance phenotypes in many fungal strains. Consequently, new alternative molecules to conventional antifungal agents are urgently needed to preven...

Descripción completa

Detalles Bibliográficos
Autores principales: Dartevelle, Pauline, Ehlinger, Claire, Zaet, Abdurraouf, Boehler, Christian, Rabineau, Morgane, Westermann, Benoit, Strub, Jean-Marc, Cianferani, Sarah, Haïkel, Youssef, Metz-Boutigue, Marie-Hélène, Marban, Céline
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6006364/
https://www.ncbi.nlm.nih.gov/pubmed/29915284
http://dx.doi.org/10.1038/s41598-018-27417-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6006364/
https://www.ncbi.nlm.nih.gov/pubmed/29915284
http://dx.doi.org/10.1038/s41598-018-27417-x

Ejemplares similares